These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7824038)

  • 1. CGP 25454A, a novel and selective presynaptic dopamine autoreceptor antagonist.
    Bischoff S; Baumann P; Krauss J; Maître L; Vassout A; Storni A; Chouinard G
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):230-8. PubMed ID: 7824038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
    Malmberg A; Jerning E; Mohell N
    Eur J Pharmacol; 1996 May; 303(1-2):123-8. PubMed ID: 8804920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of action of substituted benzamide drugs.
    Köhler C; Ogren SO; Fuxe K
    Acta Psychiatr Scand Suppl; 1984; 311():125-37. PubMed ID: 6142588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of buflomedil (4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxy phenyl)-1-butanone hydrochloride) on the function of striatal dopaminergic neurons.
    Koda H; Hashimoto T; Kuriyama K
    Jpn J Pharmacol; 1989 Feb; 49(2):215-23. PubMed ID: 2659861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    Jin S; Johansson B; Fredholm BB
    J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum.
    Niedzwiecki DM; Cubeddu LX; Mailman RB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):117-25. PubMed ID: 2746491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
    Korf J; Sebens JB
    J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [125]I-spectramide: a novel benzamide displaying potent and selective effects at the D2 dopamine receptor.
    Sánchez-Roa PM; Grigoriadis DE; Wilson AA; Sharkey J; Dannals RF; Villemagne VL; Wong DF; Wagner HN; Kuhar MJ
    Life Sci; 1989; 45(19):1821-9. PubMed ID: 2531826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-methyl-D-aspartate-evoked release of [3H]acetylcholine in striatal compartments of the rat: regulatory roles of dopamine and GABA.
    Blanchet F; Kemel ML; Gauchy C; Desban M; Perez S; Glowinski J
    Neuroscience; 1997 Nov; 81(1):113-27. PubMed ID: 9300405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization.
    Harsing LG; Sershen H; Lajtha A
    J Neurochem; 1992 Jul; 59(1):48-54. PubMed ID: 1351932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halothane enhances acetylcholine release by decreasing dopaminergic activity in rat striatal slices.
    Adachi YU; Watanabe K; Higuchi H; Satoh T; Zsilla G
    Neurochem Int; 2002 Mar; 40(3):189-93. PubMed ID: 11741001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of dopamine D1 and D2 receptors on striatal acetylcholine release in rats.
    Ikarashi Y; Takahashi A; Ishimaru H; Arai T; Maruyama Y
    Brain Res Bull; 1997; 43(1):107-15. PubMed ID: 9205804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival of intrastriatal dopaminergic grafts: modulation of acetylcholine release by graft-derived dopamine.
    Jackisch R; Duschek M; Neufang B; Rensing H; Hertting G; Herman JP
    J Neurochem; 1991 Jul; 57(1):267-76. PubMed ID: 2051168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
    J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amygdaloid kindling on [3H]dopamine and [14C]acetylcholine release from rat prefrontal cortex and striatal slices.
    Mintz M; Reyneke L; de Villiers A; Allin R; Russell V; Daniels W; van der Spuy G; Jaffer A; Kellaway L; Douglas R
    Brain Res; 1992 Oct; 592(1-2):115-21. PubMed ID: 1450903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
    Ogren SO; Hall H; Köhler C; Magnusson O; Sjöstrand SE
    Psychopharmacology (Berl); 1986; 90(3):287-94. PubMed ID: 2947255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.